Summer Symposium 2017

Convergence of Science and Engineering in Cancer poster

A leader in Convergence, MIT’s Koch Institute for Integrative Cancer Research, on June 16, 2017 presented its 16th Annual Cancer Research Symposium: Convergence of Science and Engineering in Cancer. Convergence—the merging of historically distinct disciplines such as engineering, physics, computer science, chemistry, mathematics, and the life sciences—has created extraordinary opportunities in cancer research and care. Leaders in this emerging field discussed innovative new approaches and technologies to better detect, monitor, treat, and prevent cancer. The symposium also featured a panel of experts to discuss the impact of Convergence on the future of medical care.

Agenda

Introductions and Keynote

Tyler Jacks
Welcome

Tyler Jacks
Director, Koch Institute, MIT
David H. Koch Professor of Biology, MIT

Watch video

Phil Sharp
Introduction

Phillip A. Sharp, PhD
Institute Professor, MIT
Koch Institute, MIT

Watch video

Eric Lander
Keynote Speaker: 30 Years of Convergence

Eric Lander, PhD
President and Founding Director, Broad Institute of Harvard and MIT
Professor of Biology, Department of Biology, MIT
Koch Institute, MIT
Professor of Systems Biology, Harvard Medical School

Watch video

 


Session I: A New View

Xiaowei Zhuang
Illuminating biology at the nanoscale and systems scale using single-molecule and super-resolution imaging

Xiaowei Zhuang, PhD
David B. Arnold Professor of Science, Harvard University

Watch video

Daniel Larson
Understanding transcription and splicing heterogeneity in cancer progression

Daniel Larson, PhD
NIH Stadtman Investigator, Center for Cancer Research
Head, Systems Biology of Gene Expression, National Cancer Institute

Watch video


Session II: Complex Molecular Networks

Aviv Regev
Dissecting the tumor ecosystem with single cell genomics

Aviv Regev, PhD
Director, Klarman Cell Observatory and Cell Circuits Program, Broad Institute of Harvard and MIT 
Professor of Biology, Department of Biology, MIT
Koch Institute, MIT

Gad Getz
Cancer Genome and the Cloud

Gad A. Getz, PhD
Director, Cancer Genome Computational Analysis Group, Broad Institute of Harvard and MIT

Franziska Michor
Computational Models of Cancer

Franziska Michor, PhD
Professor of Computational Biology, Dana-Farber Cancer Institute
Harvard T.H. Chan School of Public Health

Watch video


Panel: Convergence in Health

Moderated by: Susan Hockfield, PhD
President Emerita, MIT
Professor of Neuroscience, MIT
Koch Institute, MIT

Watch video

Cori Bargmann

Cori Bargmann, PhD
President of Science, Chan Zuckerberg Initiative
Torsten N. Wiesel Professor, The Rockefeller University

Marc Casper

Marc N. Casper, MBA
President and CEO, Thermo Fisher Scientific

Victor Dzau

Victor Dzau, MD
President, National Academy of Medicine

Tyler Jacks

Tyler Jacks, PhD
Director, Koch Institute, MIT
David H. Koch Professor of Biology, MIT

Nancy Simonian

Nancy Simonian, MD
CEO, Syros Pharmaceuticals, Inc.

Elias Zerhouni

Elias Zerhouni, MD
President for Global Research and Development, Sanofi
Former Director, NIH


Session III: Nanomedicine

James Collins
Synthetic biology and next-generation diagnostics

James Collins, PhD
Termeer Professor of Medical Engineering and Science and Professor of Biological Engineering, MIT
Broad Institute of Harvard and MIT
Wyss Institute

Watch video

Paula Hammond
Targeting Aggressive Cancers Nanolayers at a Time: A Platform Approach to Engineered Nanomedicine

Paula T. Hammond, PhD
David H. Koch Professor in Engineering, MIT
Head of the Department of Chemical Engineering, MIT
Koch Institute, MIT

Watch video

Chad Mirkin
Spherical Nucleic Acids as a Powerful New Platform for Cancer Therapy

Chad A. Mirkin, PhD
Director, International Institute for Nanotechnology
George B. Rathmann Professor of Chemistry, Department of Chemistry, Northwestern University 

Watch video

Bob Langer
New chemical engineering approaches to convergence

Robert S. Langer, ScD
David H. Koch Institute Professor, MIT
Koch Institute, MIT

Watch video


Closing remarks by Dr. Tyler Jacks

Watch video

Supporters

Affiliates

Janssen Research & Development, LLC
Thermo Fisher Scientific

Collaborators

Agilent Technologies
Bayer HealthCare, LLC
Sanofi

Patrons

Amgen
BioPharma Executive Council
Cell Signaling Technology, Inc.
Lumicell, Inc.

Friends

Genentech, Inc.
IOP Publishing
Molquant, Inc.
New England Biolabs
Red Sky Partners, LLC
SQZ Biotech

Vendors

Agilent Technologies
BioLegend
Cell Press
Cell Signaling Technology, Inc.
MilliporeSigma
Qiagen
Precision Biosystems
Taconic
TCI America
Thermo Fisher Scientific
Transnetyx, Inc.

Special thanks to the Kavli Foundation